Health Highlights: March 28, 2022
Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more Second COVID-19 vaccine boosters to be offered to Americans over 50. OptionalContinue Reading










